| Dynamic changes in pro-and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease A Pisanu, D Lecca, G Mulas, J Wardas, G Simbula, S Spiga, AR Carta Neurobiology of disease 71, 280-291, 2014 | 300 | 2014 |
| Behavioural sensitization after repeated exposure to Δ9-tetrahydrocannabinol and cross-sensitization with morphine C Cadoni, A Pisanu, M Solinas, E Acquas, G Chiara Psychopharmacology 158, 259-266, 2001 | 234 | 2001 |
| Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive … AR Carta, L Frau, A Pisanu, J Wardas, S Spiga, E Carboni Neuroscience 194, 250-261, 2011 | 157 | 2011 |
| Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo E Acquas, A Pisanu, P Marrocu, G Di Chiara European journal of pharmacology 401 (2), 179-185, 2000 | 98 | 2000 |
| Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson’s disease? AR Carta, A Pisanu Neurotoxicity research 23, 112-123, 2013 | 79 | 2013 |
| Δ9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study E Acquas, A Pisanu, P Marrocu, SR Goldberg, G Di Chiara European journal of pharmacology 419 (2-3), 155-161, 2001 | 70 | 2001 |
| Intravenous administration of ecstasy (3, 4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo E Acquas, P Marrocu, A Pisanu, C Cadoni, G Zernig, A Saria, G Di Chiara European journal of pharmacology 418 (3), 207-211, 2001 | 70 | 2001 |
| Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats AA Martinez, MG Morgese, A Pisanu, T Macheda, MA Paquette, A Seillier, ... Neurobiology of disease 74, 295-304, 2015 | 68 | 2015 |
| Do PPAR‐Gamma Agonists Have a Future in Parkinson′ s Disease Therapy? AR Carta, A Pisanu, E Carboni Parkinson’s disease 2011 (1), 689181, 2011 | 63 | 2011 |
| Differential effects of intravenous R, S‐(±)‐3, 4‐methylenedioxymethamphetamine (MDMA, Ecstasy) and its S (+)‐and R (−)‐enantiomers on dopamine transmission and extracellular … E Acquas, A Pisanu, S Spiga, A Plumitallo, G Zernig, GD Chiara Journal of neurochemistry 102 (1), 121-132, 2007 | 63 | 2007 |
| Modulation of Δ9-THC-induced increase of cortical and hippocampal acetylcholine release by μ opioid and D1 dopamine receptors A Pisanu, E Acquas, S Fenu, G Di Chiara Neuropharmacology 50 (6), 661-670, 2006 | 59 | 2006 |
| Effect of 3, 4-methylendioxymethamphetamine (MDMA,“ecstasy”) on dopamine transmission in the nucleus accumbens shell and core C Cadoni, M Solinas, A Pisanu, G Zernig, E Acquas, G Di Chiara Brain research 1055 (1-2), 143-148, 2005 | 58 | 2005 |
| Withania somnifera Prevents Morphine Withdrawal-Induced Decrease in Spine Density in Nucleus Accumbens Shell of Rats: A Confocal Laser Scanning … S Kasture, S Vinci, F Ibba, A Puddu, M Marongiu, B Murali, A Pisanu, ... Neurotoxicity research 16, 343-355, 2009 | 51 | 2009 |
| Immunomodulatory drugs alleviate l‐dopa‐induced dyskinesia in a rat model of Parkinson's disease L Boi, A Pisanu, NH Greig, MT Scerba, D Tweedie, G Mulas, S Fenu, ... Movement Disorders 34 (12), 1818-1830, 2019 | 49 | 2019 |
| Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function A Pisanu, L Boi, G Mulas, S Spiga, S Fenu, AR Carta Journal of Neural Transmission 125, 1287-1297, 2018 | 43 | 2018 |
| Impairment of acquisition of intravenous cocaine self-administration by RNA-interference of dopamine D1-receptors in the nucleus accumbens shell A Pisanu, D Lecca, V Valentini, A Bahi, JL Dreyer, F Cacciapaglia, A Scifo, ... Neuropharmacology 89, 398-411, 2015 | 35 | 2015 |
| Lesion of medial prefrontal dopamine terminals abolishes habituation of accumbens shell dopamine responsiveness to taste stimuli Z Bimpisidis, MA De Luca, A Pisanu, G Di Chiara European Journal of Neuroscience 37 (4), 613-622, 2013 | 29 | 2013 |
| Advances in modelling alpha-synuclein-induced Parkinson’s diseases in rodents: virus-based models versus inoculation of exogenous preformed toxic species AR Carta, L Boi, A Pisanu, MF Palmas, E Carboni, A De Simone Journal of Neuroscience Methods 338, 108685, 2020 | 26 | 2020 |
| Adolescent cannabis exposure increases heroin reinforcement in rats genetically vulnerable to addiction D Lecca, A Scifo, A Pisanu, V Valentini, G Piras, A Sil, C Cadoni, ... Neuropharmacology 166, 107974, 2020 | 25 | 2020 |
| Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence C Cadoni, A Pisanu, N Simola, L Frau, PF Porceddu, S Corongiu, C Dessì, ... Neuropharmacology 123, 385-394, 2017 | 22 | 2017 |
Prof Gaetano Di ChiaraProfessor of Pharmacology University of Cagliari, Italy在 unica.it 的电子邮件经过验证
Prof Gaetano Di ChiaraProfessor of Pharmacology University of Cagliari, Italy在 unica.it 的电子邮件经过验证
Amine BAHI, PhDAjman University在 ajman.ac.ae 的电子邮件经过验证